The US Preventive Services Taskforce is recommending against initiating low-dose aspirin for the primary prevention of CVD in adults aged 60 years or older. And the Task Force is lukewarm on the benefit in younger people 40-59 years even with a 10% or greater 10-year CV risk based on the ACC/AHA risk calculator. “The USPSTF ...
Low-dose aspirin review says no for CVD prevention in over 60s
By Mardi Chapman
14 Oct 2021